Sridharan, V., Nandana, D., Choo, H. X., Gamble, V., Thakurta, A., Flynt, E. (2025). Ktx-1001, a potent, selective MMSET/NSD2 inhibitor, enhances immunomodulatory and immune-directed therapies in preclinical models of multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-7456